Unknown

Dataset Information

0

Clinical Predictors of Response to Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders: The Genes for Treatment (GxT) Study.


ABSTRACT:

Objective

The Genes for Treatment study is an international, multisite collaboration exploring the role of genetic, demographic, and clinical predictors in response to cognitive-behavioral therapy (CBT) in pediatric anxiety disorders. The current article, the first from the study, examined demographic and clinical predictors of response to CBT. We hypothesized that the child's gender, type of anxiety disorder, initial severity and comorbidity, and parents' psychopathology would significantly predict outcome.

Method

A sample of 1,519 children 5 to 18 years of age with a primary anxiety diagnosis received CBT across 11 sites. Outcome was defined as response (change in diagnostic severity) and remission (absence of the primary diagnosis) at each time point (posttreatment, 3-, 6-, and/or 12-month follow-up) and analyzed using linear and logistic mixed models. Separate analyses were conducted using data from posttreatment and follow-up assessments to explore the relative importance of predictors at these time points.

Results

Individuals with social anxiety disorder (SoAD) had significantly poorer outcomes (poorer response and lower rates of remission) than those with generalized anxiety disorder (GAD). Although individuals with specific phobia (SP) also had poorer outcomes than those with GAD at posttreatment, these differences were not maintained at follow-up. Both comorbid mood and externalizing disorders significantly predicted poorer outcomes at posttreatment and follow-up, whereas self-reported parental psychopathology had little effect on posttreatment outcomes but significantly predicted response (although not remission) at follow-up.

Conclusion

SoAD, nonanxiety comorbidity, and parental psychopathology were associated with poorer outcomes after CBT. The results highlight the need for enhanced treatments for children at risk for poorer outcomes.

SUBMITTER: Hudson JL 

PROVIDER: S-EPMC4469376 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Predictors of Response to Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders: The Genes for Treatment (GxT) Study.

Hudson Jennifer L JL   Keers Robert R   Roberts Susanna S   Coleman Jonathan R I JR   Breen Gerome G   Arendt Kristian K   Bögels Susan S   Cooper Peter P   Creswell Cathy C   Hartman Catharina C   Heiervang Einar R ER   Hötzel Katrin K   In-Albon Tina T   Lavallee Kristen K   Lyneham Heidi J HJ   Marin Carla E CE   McKinnon Anna A   Meiser-Stedman Richard R   Morris Talia T   Nauta Maaike M   Rapee Ronald M RM   Schneider Silvia S   Schneider Sophie C SC   Silverman Wendy K WK   Thastum Mikael M   Thirlwall Kerstin K   Waite Polly P   Wergeland Gro Janne GJ   Lester Kathryn J KJ   Eley Thalia C TC  

Journal of the American Academy of Child and Adolescent Psychiatry 20150401 6


<h4>Objective</h4>The Genes for Treatment study is an international, multisite collaboration exploring the role of genetic, demographic, and clinical predictors in response to cognitive-behavioral therapy (CBT) in pediatric anxiety disorders. The current article, the first from the study, examined demographic and clinical predictors of response to CBT. We hypothesized that the child's gender, type of anxiety disorder, initial severity and comorbidity, and parents' psychopathology would significa  ...[more]

Similar Datasets

| S-EPMC6371410 | biostudies-literature
| S-EPMC4744149 | biostudies-literature
| S-EPMC3376684 | biostudies-literature